- $229.72m
- $159.44m
- $194.06m
U.S. STOCKS ON THE MOVE-General Motors, CoreWeave , Gold Miners
LifeMD climbs after offering Novo's Ozempic at $499 a month
LifeMD to offer Novo's Ozempic at $499 a month to eligible US cash-paying customers (updated)
LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers
U.S. STOCKS ON THE MOVE-Novavax, copper miners, Apple
U.S. STOCKS ON THE MOVE-Novavax, Copper miners, Apple
LifeMD slumps after firm cuts 2025 revenue forecast
LifeMD Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: LifeMD Q2 Revenue USD 62.2 Million Vs. IBES Estimate USD 66.3 Million
LifeMD Inc expected to post a loss of 1 cent a share - Earnings Preview
Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price (updated)
Timeline: From insulin to Ozempic, history of Novo Nordisk's CEOs
LifeMD Inc reports results for the quarter ended March 31 - Earnings Summary
LifeMD Inc expected to post a loss of 5 cents a share - Earnings Preview
Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform
Hims & Hers to sell Lilly's Zepbound on its telehealth platform (updated)
Hims & Hers to sell Lilly's Zepbound on its telehealth platform
U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
U.S. STOCKS ON THE MOVE-BankUnited, Hesai Group, Sezzle